TME Pharma N.V. (ALTME) — Cash Flow Quality Index

Latest as of December 2019: -1.47x

TME Pharma N.V. (ALTME) has a Cash Flow Quality Index of -1.47x as of December 2019. Operating cash flow of €-1.60 Million is below net income of €1.09 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ALTME strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.47x

Operating CF / Net Income

Operating Cash Flow

€-1.60 Million

EUR

Net Income

€1.09 Million

EUR

Data as of

Dec 2019

Most recent filing

Annual Cash Flow Quality Index for TME Pharma N.V. (None–None)

Year-by-year earnings quality comparison for TME Pharma N.V.. For live market cap and the full company financial profile, see TME Pharma N.V. market cap and net worth.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.